Induction of Tissue Factor Expression in Whole Blood: Lack of Evidence for the Presence of Tissue Factor Expression in Granulocytes

Bjarne Østerud; L. Vijaya Mohan Rao; Jan Ole Olsen

doi:10.1055/s-0037-1613934

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 2000; 83(06): 861-867
DOI: 10.1055/s-0037-1613934

Commentary

Schattauer GmbH

Induction of Tissue Factor Expression in Whole Blood: Lack of Evidence for the Presence of Tissue Factor Expression in Granulocytes

Authors

Bjarne Østerud

¹From the Department of Biochemistry, Institute of Medical Biology, Faculty of Medicine, University of Tromsø, Tromsø, Norway
L. Vijaya Mohan Rao

²Department of Biochemistry, The University of Texas Health Centre, Tyler, Texas, USA
Jan Ole Olsen

¹From the Department of Biochemistry, Institute of Medical Biology, Faculty of Medicine, University of Tromsø, Tromsø, Norway

Abstract

Summary

The present investigation was undertaken to explore the effect of platelets, tumor necrosis factor (TNF) and phorbel ester [phorbol 12-myristate 13-acetate (PMA)] on lipopolysaccharide (LPS)-induced tissue factor (TF) activity and TF antigen by using Western blot and ELISA-techniques. LPS was found to induce correlating levels of TF antigen and the activity in monocytes. TNF and PMA, when used alone, failed to induce TF activity and the antigen in monocytes, but enhanced the LPS-induced TF activity and the antigen by 2 to 3-fold. Addition of platelet rich plasma to isolated blood cells enhanced the LPS-induced TF activity but not the antigen levels in monocytes. In contrast to whole platelets, platelet lysates enhanced both LPS-induced TF activity and the antigen. Granulocytes isolated from heparinized plasma incubated for 2 or 24 h with LPS alone or together with PMA, failed to generate TF antigen or the activity. Although granulocyte preparations isolated from whole blood that was incubated for 24 h with LPS and PMA apparently possessed a significant amount of TF activity and the antigen, this could be accounted for by trace levels of contaminating monocytes. Upregulation of LPS-induced TF activity but not the antigen by platelets in the presence of granulocytes suggests that the increased TF activity could be the result of PS enrichment of monocytes by fusion or platelets with activated monocytes.

Key words

Tissue factor - granulocytes - monocytes - platelets - LPS

Volltext

Referenzen

References
1 Østerud B, Rapaport SI. Activation of factor IX by the reaction product of tissue factor and factor VII: an additional pathway for initiating blood coagulation. Proc Natl Acad Sci 1977; 74: 5260-4.
2 Rapaport SI, Rao LVM. The tissue factor pathway: How it has become a Prima Ballerina. Thromb Haemost 1995; 74: 7-17.
3 Nemerson Y. Tissue factor: Then and now. Thromb Haemost 1995; 74: 180-4.
4 Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues: implication for disorders of hemostasis and thrombosis. Am J Pathol 1988; 86: 1087-97.
5 Fleck RA, Rao LMV, Rapaport SI, Varki N. Localization of tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody. Thromb Res 1990; 57: 765-81.
6 Colluci M, Balconi G, Lorenzet R, Pietra A, Locati D. Cultured human endothelial cells generate tissue factor in response to endotoxin. J Clin Invest 1983; 71: 1893-6.
7 Lyberg T, Galdal KS, Evensen SA, Prydz H. Cellular cooperation in endothelial cell thromboplastin synthesis. Br J Haematol 1983; 53: 85-95.
8 Brox JH, Østerud B, Bjørklid E, Fenton JW. Production and availability of thromboplastin in endothelial cells: the effects of thrombin, endotoxin and platelets. Br J Haematol 1984; 57: 239-46.
9 Camerer E, Kolstø A-B, Prydz H. Cell biology of tissue factor, the principal initiator of blood coagulation. Thromb Res 1996; 81: 1-41.
10 Contrino J, Hair G, Kreutzer DL, Rickles FR. In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease. Nat Med 1996; 02: 209-15.
11 Drake TA, Cheng J, Chang A, Taylor Jr. FB. Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal E. coli sepsis. Am J Pathol 1993; 142: 1458-70.
12 Østerud B, Flaegstad T. Increased thromboplastin activity in monocytes of patients with meningococcal infection: Related to an unfavourable prognosis. Thromb Haemost 1983; 49: 5-7.
13 Leatham EW, Bath PM, Tozze JA, Camm AJ. Increased monocyte tissue factor expression in coronary disease. Br Heart J 1995; 73: 10-3.
14 Annex BH, Denning SM, Channon KM, Sketch Jr MH, Stack RS, Morrissey JH, Peters KG. Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes. Circulation 1995; 91: 619-22.
15 Moreno PR, Bernardi VH, Lopez-Cuellar J, Murcia AM, Palacios IF, Gold HK, Mehran R, Sharma SK, Nemerson Y, Fuster V, Fallon JT. Macrophages, smooth muscle cells, and tissue factor in unstable angina. Implications for cell-mediated thrombogenicity in acute coronary syndromes. Circulation 1996; 94: 3090-7.
16 Østerud B. Tissue factor expression by monocytes: regulation and pathophysiological role. Blood Coag and Fibrinol 1998; 09: S9-S14.
17 Østerud B, Due JH. Blood coagulation in patients with benign and malignant tumors before and after surgery. Special reference to thromboplastin generation in monocytes. Scand J Haematol 1984; 32: 258-64.
18 Østerud B, Olsen JO, Wilsgaard L. The role of arachidonic release and lipoxygenase pathway in lipopolysaccharide-induced thromboplastin activity in monocytes. Blood Coag and Fibrinol 1990; 01: 41-6.
19 Halvorsen H, Olsen JO, Østerud B. Granulocytes enhance LPS-induced tissue factor activity in monocytes via an interaction between platelets. J Leuk Biol 1993; 54: 275-82.
20 Rao LVM, Pendurthi UR. Tissue factors on cells. Blood Coag Fibrinol 1998; 09 (Suppl. 01) S27-S35.
21 Drake TA, Ruf W, Morrissey JH, Edgington TS. Functional tissue factor is entirely cell surface expressed on lipopolysaccharide-stimulated human blood monocytes and a constitutively tissue factor-producing neoplastic cell line. J Cell Biol 1989; 109: 389-95.
22 Higure A, Okamoto K, Hirata K, Todoroki H, Nagafuchi Y, Takeda S, Katoh H, Itoh H, Ohsato K, Nakamura S. Macrophages and neutrophils infiltrating into the liver are responsible for tissue factor expression in a rabbit model of acute obstructive cholangitis. Thromb Haemost 1996; 75: 791-5.
23 Korsgaard N, Elm T, Nielsen LS, Ezban M, Hedner U, Kristensen AT. Infiltrating neutrophils are a major source of tissue factor (TF) in rabbit arteries after mechanical injury. Blood 1997; 90 (Suppl. 01) 285a (abstr 1255).
24 Giesen PL, Rauch U, Bohrmann B, Kling D, Roque M, Fallon JT, Badimon JJ, Himber J, Riederer MA, Nemerson Y. Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci USA 1999; 96: 2311-5.
25 Sissener CEngstad, Rekdal Ø, Olsen JO, Østerud B. A novel biological effect of platelet factor 4 (PF4): Enhancement of LPS-induced tissue factor activity in monocytes. J Leuk Biol 1995; 58: 575-81.
26 Fleck RA, Rao LVM, Rapaport SI, Varki N. Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody. Thromb Res 1990; 59: 421-37.
27 Ernofsson M, Siegbahn A. Platelet-derived growth factor-BB and monocyte chemotactic protein-1 induce human peripheral blood monocytes to express tissue factor. Thromb Res 1996; 83: 307-20.
28 Hair GA, Padula S, Zeff R, Schmeizl M, Contrino J, Kreutzer DL, de Moerloose P, Boyd AW, Stanley I, Burgess AW, Rickles FR. Tissue factor expression in human leukemic cells. Leuk Res 1996; 20: 1-11.
29 Geng JG, Moore KL, Johnson AE, McEver RP. Neutrophil recognition requires a Ca(2+)-induced conformational change in the lectin domain of GMP-140. J Biol Chem 1991; 266: 22313-8.
30 Kjalke M, Sørensen O, Borregaard N, Ezban M, Kristensen AT. Tissue factor expression by rabbit and human neutrophils. Thromb Haemost 1999; (Suppl); 761 (abstract 2404).
31 Timmerman JJ, Keller TT, Reitsma PH, ten Cate H. Tissue factor expression by human granulocytes is regulated by lipopolysaccharide (LPS). Thromb Haemost 1999; (Suppl); 701 (abstract 2213).